Author Question: A postpartum patient is being evaluated for depression. Which manifestations would the nurse assess ... (Read 48 times)

ashley

  • Hero Member
  • *****
  • Posts: 584
A postpartum patient is being evaluated for depression. Which manifestations would the nurse assess in this patient? (Select all that apply.)
 
  A) Tearful
  B) Confusion
  C) Hyperactivity
  D) Lack of motivation
  E) Sadness and anxiety

Question 2

When assessing the patient for postpartum hemorrhage what should the nurse monitor every hour?
 
  A) Complete blood count
  B) Vital signs
  C) Pad count
  D) Urine volume excreted



pallen55

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

Ans: A, D, E

Answer to Question 2

Ans: C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library